- Home
- RF vs NTRA Comparison
RF vs NTRA Comparison
Compare RF & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RF
- NTRA
- Stock Information
- Founded
- RF 1970
- NTRA 2003
- Country
- RF United States
- NTRA United States
- Employees
- RF N/A
- NTRA N/A
- Industry
- RF Major Banks
- NTRA Medical Specialities
- Sector
- RF Finance
- NTRA Health Care
- Exchange
- RF Nasdaq
- NTRA Nasdaq
- Market Cap
- RF 17.4B
- NTRA 18.4B
- IPO Year
- RF N/A
- NTRA 2015
- Fundamental
- Price
- RF $19.31
- NTRA $148.08
- Analyst Decision
- RF Buy
- NTRA Strong Buy
- Analyst Count
- RF 19
- NTRA 17
- Target Price
- RF $26.42
- NTRA $176.65
- AVG Volume (30 Days)
- RF 12.7M
- NTRA 1.6M
- Earning Date
- RF 04-17-2025
- NTRA 05-08-2025
- Dividend Yield
- RF 5.15%
- NTRA N/A
- EPS Growth
- RF 11.56
- NTRA N/A
- EPS
- RF 2.07
- NTRA N/A
- Revenue
- RF $6,661,000,000.00
- NTRA $1,696,911,000.00
- Revenue This Year
- RF $17.04
- NTRA $15.33
- Revenue Next Year
- RF $4.31
- NTRA $18.50
- P/E Ratio
- RF $9.32
- NTRA N/A
- Revenue Growth
- RF N/A
- NTRA 56.75
- 52 Week Low
- RF $17.72
- NTRA $83.13
- 52 Week High
- RF $27.96
- NTRA $183.00
- Technical
- Relative Strength Index (RSI)
- RF 39.56
- NTRA 50.83
- Support Level
- RF $17.74
- NTRA $125.38
- Resistance Level
- RF $19.82
- NTRA $152.66
- Average True Range (ATR)
- RF 1.19
- NTRA 8.82
- MACD
- RF -0.00
- NTRA 1.47
- Stochastic Oscillator
- RF 36.43
- NTRA 82.19
About RF Regions Financial Corporation
Regions Financial is a regional bank based in Alabama, with branches primarily in the Southeastern and Midwestern United States. Regions primarily provides traditional commercial and retail banking and also offers mortgage services, asset management, wealth management, securities brokerage, and trust services.
About NTRA Natera Inc.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.